These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37697722)

  • 1. Computational evaluation of phytochemicals targeting DNA topoisomerase I in
    Arya PK; Mandal P; Barik K; Singh DV; Kumar A
    J Biomol Struct Dyn; 2024 Oct; 42(16):8293-8306. PubMed ID: 37697722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
    Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
    Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
    Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
    Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug designing against
    Sarma M; Borkotoky S; Dubey VK
    J Biomol Struct Dyn; 2024 Sep; 42(14):7628-7636. PubMed ID: 37491862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
    Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of thiamine pyrophosphokinase of vitamin B1 biosynthetic pathway as a drug target of
    Ranjan Kumar R; Jain R; Akhtar S; Parveen N; Ghosh A; Sharma V; Singh S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5669-5685. PubMed ID: 37350670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors.
    Mamidala R; Majumdar P; Jha KK; Bathula C; Agarwal R; Chary MT; Majumder HK; Munshi P; Sen S
    Sci Rep; 2016 May; 6():26603. PubMed ID: 27221589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing based novel anti-leishmanial drug screening using
    Rai P; Arya H; Saha S; Kumar D; Bhatt TK
    J Biomol Struct Dyn; 2022; 40(21):10812-10820. PubMed ID: 36529188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
    Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
    J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy.
    Chowdhury AR; Mandal S; Goswami A; Ghosh M; Mandal L; Chakraborty D; Ganguly A; Tripathi G; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
    Mol Med; 2003; 9(1-2):26-36. PubMed ID: 12765337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel betulin derivatives as antileishmanial agents with mode of action targeting type IB DNA topoisomerase.
    Chowdhury S; Mukherjee T; Sengupta S; Chowdhury SR; Mukhopadhyay S; Majumder HK
    Mol Pharmacol; 2011 Oct; 80(4):694-703. PubMed ID: 21750153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
    Carballeira NM; Cartagena M; Sanabria D; Tasdemir D; Prada CF; Reguera RM; Balaña-Fouce R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6185-9. PubMed ID: 22932312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
    Ray S; Hazra B; Mittra B; Das A; Majumder HK
    Mol Pharmacol; 1998 Dec; 54(6):994-9. PubMed ID: 9855627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors.
    Mohamed MA; Elsaman T; Elderdery AY; Alsrhani A; Ghanem HB; Alruwaili MM; Hamza SMA; Mekki SEI; Alotaibi HA; Mills J
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new bisbenzylisoquinoline alkaloid isolated from Thalictrum foliolosum, as a potent inhibitor of DNA topoisomerase IB of Leishmania donovani.
    Kumar A; Chowdhury SR; Sarkar T; Chakrabarti T; Majumder HK; Jha T; Mukhopadhyay S
    Fitoterapia; 2016 Mar; 109():25-30. PubMed ID: 26625837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo.
    Saha S; Mukherjee T; Chowdhury S; Mishra A; Chowdhury SR; Jaisankar P; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2013 Dec; 86(12):1673-87. PubMed ID: 24134912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
    Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
    J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.